Investigating nanoparticle's utilization in stem cell therapy for neurological disorders.

IF 1.5 Q4 CELL BIOLOGY
American journal of stem cells Pub Date : 2025-04-15 eCollection Date: 2025-01-01 DOI:10.62347/YGYM4976
Sadia Aziz, Sundus Anbreen, Shaheen Shahzad, Muhammad Saad Ahmed, Vivek Sharma, Jing Yang, Liaqat Ali
{"title":"Investigating nanoparticle's utilization in stem cell therapy for neurological disorders.","authors":"Sadia Aziz, Sundus Anbreen, Shaheen Shahzad, Muhammad Saad Ahmed, Vivek Sharma, Jing Yang, Liaqat Ali","doi":"10.62347/YGYM4976","DOIUrl":null,"url":null,"abstract":"<p><p>Stem cell therapy is a promising area of regenerative medicine, offering potential treatments for various life-threatening disorders. Stem cells are classified based on their differentiation potential into totipotent, pluripotent, and multipotent stem cells. Among them, mesenchymal stem cells (MSCs) are widely used in regenerative medicine due to their tissue regeneration capabilities and ability to differentiate into multiple cell types. Stem cells are being explored for treating neurodegenerative disorders like Parkinson's, Alzheimer's, Huntington's, and amyotrophic lateral sclerosis (ALS). These conditions result from progressive neuronal degeneration, leading to irreversible damage. Challenges such as cell survival, immune rejection, tumor formation, and ethical concerns related to embryonic stem cells need to be addressed. Nanotechnology is emerging as a tool for enhancing stem cell therapy, improving targeted delivery and effectiveness. Nanoparticles possess the ability to create microenvironments as substrates, facilitate targeted administration, and enable real-time, precise imaging of stem cells. This review explores the integration of stem cells and nanotechnology as regenerative medicine tool for neurodegenerative disease treatment, analyzing current strategies and therapeutic approaches. Integrating nanotechnology with stem cell therapy may significantly improve targeted delivery and enhance regenerative outcomes for neurodegenerative disorders.</p>","PeriodicalId":7657,"journal":{"name":"American journal of stem cells","volume":"14 1","pages":"1-13"},"PeriodicalIF":1.5000,"publicationDate":"2025-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12089827/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of stem cells","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.62347/YGYM4976","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Stem cell therapy is a promising area of regenerative medicine, offering potential treatments for various life-threatening disorders. Stem cells are classified based on their differentiation potential into totipotent, pluripotent, and multipotent stem cells. Among them, mesenchymal stem cells (MSCs) are widely used in regenerative medicine due to their tissue regeneration capabilities and ability to differentiate into multiple cell types. Stem cells are being explored for treating neurodegenerative disorders like Parkinson's, Alzheimer's, Huntington's, and amyotrophic lateral sclerosis (ALS). These conditions result from progressive neuronal degeneration, leading to irreversible damage. Challenges such as cell survival, immune rejection, tumor formation, and ethical concerns related to embryonic stem cells need to be addressed. Nanotechnology is emerging as a tool for enhancing stem cell therapy, improving targeted delivery and effectiveness. Nanoparticles possess the ability to create microenvironments as substrates, facilitate targeted administration, and enable real-time, precise imaging of stem cells. This review explores the integration of stem cells and nanotechnology as regenerative medicine tool for neurodegenerative disease treatment, analyzing current strategies and therapeutic approaches. Integrating nanotechnology with stem cell therapy may significantly improve targeted delivery and enhance regenerative outcomes for neurodegenerative disorders.

研究纳米粒子在神经系统疾病干细胞治疗中的应用。
干细胞治疗是再生医学的一个有前途的领域,为各种危及生命的疾病提供了潜在的治疗方法。干细胞根据其分化潜能分为全能干细胞、多能干细胞和多能干细胞。其中,间充质干细胞(mesenchymal stem cells, MSCs)因其具有组织再生能力和分化为多种细胞类型的能力而被广泛应用于再生医学。干细胞正在被用于治疗神经退行性疾病,如帕金森氏症、阿尔茨海默氏症、亨廷顿氏症和肌萎缩侧索硬化症(ALS)。这些情况是由进行性神经元变性引起的,导致不可逆的损伤。诸如细胞存活、免疫排斥、肿瘤形成以及与胚胎干细胞相关的伦理问题等挑战需要解决。纳米技术正在成为加强干细胞治疗、改善靶向递送和有效性的工具。纳米颗粒具有创造微环境作为基质的能力,促进靶向给药,并实现干细胞的实时,精确成像。这篇综述探讨了干细胞和纳米技术作为再生医学治疗神经退行性疾病的工具,分析了目前的策略和治疗方法。将纳米技术与干细胞疗法相结合可以显著改善靶向递送,并提高神经退行性疾病的再生结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信